Azithromycin for the cure of Helicobacter pylori infection

American Journal of Gastroenterology

Volumn 91, Issue 2, 1996, Pages 264-267

  Di Mario, F ^a   Dal Bo N ^b   Grassi, S A ^b   Rugge, M ^b   Cassaro, M ^b   Donisi, P M ^b   Vianello, F ^b   Kusstatscher, S ^b   Salandin, S ^b   Grasso, G A ^b   Ferrana, M ^b   Battaglia, G ^b  

^a Cattedra Malattie Apparato Digerente   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BISMUTH CITRATE; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ANTIMICROBIAL ACTIVITY; ARTICLE; CHRONIC GASTRITIS; DRUG TISSUE LEVEL; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; STOMACH ULCER; ULCER HEALING;

ADULT; AGED; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; AZITHROMYCIN; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; FOLLOW-UP STUDIES; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; TIME FACTORS;

EID: 0030024995     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Graham DY. Helicobacter pylori: Its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol 1991;6:105-13.
2. Dixon MF. Helicobacter pylori and peptic ulceration: Histological aspects. J Gastroenterol Hepatol 1991;6:125-30.
3. Battaglia G, Di Mario F, Pasini M, et al. Helicobacter pylori infection, cigarette smoking and alcohol consumption. A histological and clinical study of 286 subjects. Ital J Gastroenterol 1993;25:419-24.
4. Fiocca R, Villani L, Luinetti O, Gianatti A, et al. Helicobacter colonization and histopathological profile of chronic gastritis in patients with or without dyspepsia, mucosal erosion and peptic ulcer: A morphological approach to the study of ulcerogenesis in man. Virchows Arch [A] 1992;20:489-98.
5. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric and duodenal ulcer. Ann Intern Med 1992;116:705-8.
6. Hosking SW, Ling TKW, Yung MY, et al. Randomized controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. Br Med J 1992;305:502-4.
7. Mantzaris GJ, Hatzis A, Tamvakologos G, et al. Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers healing and long-term relapse rates. Dig Dis Sci 1993;38:1132-6.
8. Vigneri S, Termini R, Scialabba A, et al. One year relapse rate after H. pylori eradication with omeprazole plus antimicrobials. Boston: AGA Annual Meeting, 1993;A1258 (abstract).
9. Bright GM, Nagel AA, Bordner J, et al. Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a homoerythromycin A derivative, A new class of macrolide antibiotics: the azalides. J Antibiot 1988; 41:1029-47.
10. Reselma J, Girard A, Schelkly W, et al. Spectrum and mode of action of azithromycin (CP-62.993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother 1987;31:1939-47.
11. Girard AE, Girard D, English AR, et al. Pharmacokinetic and in vivo studies with azithromycin (CP, 62.993): A new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother 1987;31:1948-54.
12. Fould G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25(suppl A):73-82.
13. Harrison JD, Jones JA, Morris DL. Azithromycin levels in plasma and gastric tissue, juice and mucus. Eur J Clin Microbiol Infect Dis 1991; 10:862-4.
14. McNulty CA, Dent JC, Ford GA, et al. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. J Antimicrob Chemother 1988;22:729-38.
15. Misiewicz JJ, Tytgat G, Goodwin CS, et al. The Sydney system: A new classification of gastritis. Working Party Reports of the 9th World Congress of Gastroenterology. Melbourne: Blackwell Scientific, 1989; 1-10.
16. Gray SF, Wyatt JI, Rathbone BJ. Simplified techniques for identifying Campylobacter pyloridis. J Clin Pathol 1986;39:1280-3.
17. Glupczynski Y, Burette A. Failure of azythromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment. Am J Gastroenterol 1990;85:98-9 (letter).
18. Di Mario F, Dal Bó N, Ferrana M, et al. Azithromycin: A new useful therapeutic strategy for the eradication of Helicobacter pylori infection, modification of serum gastrin, pepsinogens and anti-Hp antibodies (IgG). Gastroenterology 1994;106:A71.
19. Di Mario F, Dal Bó N, Ferrana M, et al. Azithromycin in triple therapy for eradicating Helicobacter pylori. Gut 1994;35:S2:F249.
20. Chiba N, Rao BV, Rademaker JW, et al. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992;87:1716-27.
21. Xu Ping. Omeprazole plus metronidazole or amoxicillin: Efficacy of various treatment regimens to eradicate Helicobacter pylori. Los Angeles: 10th Congress of Gastroenterology, 1994;94:67.
22. Al-Assi MT, Genta RM, Karttunen TJ, et al. Azythromycin triple therapy for Helicobacter pylori infection: Azythromycin, tetracicline, and bismuth. Am J Gastroenterol 1995;90:403-5.
23. Tytgat GNJ. Review article: Treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994;8:359-68.
24. Bazzoli F, Zagari RM, Fossi S, et al. Short term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773-7.
25. Penston GJ. Review article. Helicobacter pylori eradication: Understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994;8:369-89.